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Abstract The formation of extracellular traps (ETs) by
phagocytic cells has been recognized as a novel and
important mechanism of the host innate immune response
against infections. ETs are formed by different host immune
cells such as neutrophils, mast cells, and eosinophils after
stimulation with mitogens, cytokines, or pathogens them-
selves, in a process dependent upon induction of a reactive-
oxygen-species-mediated signaling cascade. ETs consist of
nuclear or mitochondrial DNA as a backbone with
embedded antimicrobial peptides, histones, and cell-
specific proteases and thereby provide a matrix to entrap
and kill microbes and to induce the contact system. This
review summarizes the latest research on ETs and their role
in innate immunity and host innate defense. Attention is
also given to mechanisms by which certain leading
bacterial pathogens have evolved to avoid entrapment and
killing in these specialized structures.
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Introduction
The frontline function of phagocytes such as neutrophils
and macrophages in our innate immune defense has been
classically understood to reflect a variety of potent
intracellular microbicidal mechanisms. Upon contact with
the invading pathogen, phagocytes engulf the microbes into
their phagocytic vacuoles (phagosomes). Efficient uptake is
facilitated through prior opsonization of the microbe with
circulating complement or, in the nonnaïve host, specific
antibodies recognizing epitopes on the pathogen surface.
Phagosomes subsequently fuse with intracellular granules
to form the phagolysosome, within which microbial killing
is achieved by a combination of nonoxidative and oxidative
mechanisms [1, 2]. Potent nonoxidative killing mechanisms
include antimicrobial peptides (AMPs) such as cathelicidins
and defensins and the activities of cathepsins and other
degradative proteases; the oxygen-dependent “respiratory
burst” involves the nonmitochondrial generation of antimi-
crobial reactive oxygen species (ROS) through the
membrane-bound NADPH oxidase enzyme complex.
However, beginning with a landmark study in 2004 [3],
the fundamental conception of how, and where, neutrophils
kill pathogenic microbes has been altered in a most
fascinating and provocative way. The discovery of DNA-
based antimicrobial extracellular traps (ETs) elaborated by
neutrophils (NETs) has important implications for our
understanding of the innate immune system and the
pathophysiology of infectious and inflammatory diseases.
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restricted to neutrophils but shared by other specialized
leukocytes, one has the sense that we are at the inception of
a major field of investigation whose ramifications may be
quite far-reaching. Here, we summarize current knowledge
of ETs and their functions in innate host defense.
Neutrophil extracellular traps
The phenomenon of NETs, as well as their basic structure
and function, was first discovered by Brinkmann et al.
using electron microscopy [3]. NETs were observed as a
highly decondensed chromatin structure that is formed and
released by activated neutrophils. Since treatment with
DNase led to the disintegration of NETs, DNA was
ascertained to represent the major structural component —
a backbone upon which histones, proteases (e.g. elastase),
and AMPs reside. The fibrous DNA stretches within NETs
had a diameter of 15–17 nm, punctuated with globular
protein domains ranging from ~25 nm up to large
aggregates of ~50 nm. It was surmised that the cationic
proteins embedded within the NETs such as histones or
cathelicidin AMPs confer an ability to kill entrapped
microbes. This concept was validated when efficient killing
of bacteria such as Staphylococcus aureus and Listeria
monocytogenes by neutrophils occurred even when phago-
cytosis was blocked pharmacologically (cytochalasin D, an
actin microfilament inhibitor). Moreover, this extracellular
antimicrobial activity was eliminated by DNase treatment
and dissolution of the NET architecture [3]. Our own three-
dimensional confocal micrograph of S. aureus entrapped
within human NETs is presented in Fig. 1.
A variety of different proinflammatory stimuli have been
shown to activate the formation of ETs (Table 1), including
hydrogen peroxide (H2O2), bacterial lipopolysaccharide
(LPS), the mitogen phorbol myristate acetate (PMA), and
the CXC family chemokine interleukin 8 (IL-8) [3, 4]. The
chemotactic complement-derived peptide complement fac-
tor 5a (C5a) can also stimulate NET formation but only
after mature neutrophils are primed with interferons or
granulocyte macrophage colony-stimulating factor (GM-
CSF) [5]; no such priming step is required for NET
induction with LPS, PMA, or IL-8 [3]. Platelets activated
in a TLR4-dependent fashion can also induce NETs,
promoting the trapping of bacteria within blood vessels
[6]. And as would befit a critical innate immune process,
direct exposure to a variety of different microbial pathogens
is sufficient to trigger NET formation, including S. aureus
[4], Streptococcus pyogenes [7], Mycobacterium tuberculo-
sis [8], Escherichia coli [9], hyphae or yeast forms of
Candida albicans [10], and the protozoan parasite Leish-
mania amazonensis [11]. Studies with C. albicans suggest
that prior opsonization of the pathogen can increase the
NET response [10]. Recently, an individual bacterial
protein, the surface-anchored and soluble M1 protein of S.
pyogenes, was found sufficient to induce NET formation
[12, 13], adding to its described proinflammatory properties
[14]. Surface lipophosphoglycan purified from L. amazo-
nensis is also capable of inducing nets in a dose-dependent
fashion [11].
Knowledge is beginning to emerge regarding the cellular
processes that precede the formation of NETs by activated
neutrophils (summarized in Fig. 2). Evidence implicates the
production of ROS such as superoxide (O2
−)o rH 2O2 as an
essential signal leading to the induction of unique cell death
Fig. 1 Bacterial entrapment in
NETs: three-dimensional confo-
cal micrograph of FITC-labeled
S. aureus (strain Cowan)
entrapped by human neutrophil
extracellular traps, as visualized
by the blue DNA dye DAPI
776 J Mol Med (2009) 87:775–783program and the elaboration of NETs [4]. Interference with
ROS generation using diphenylene iodonium (DPI), an
inhibitor of NADPH oxidase enzymes, blocks the formation
of NETs. This process is morphologically distinct from
other classical cell death processes including apoptosis and
necrosis and hence was dubbed “NETosis” [15]. One key
biochemical marker of NET formation appears to be the
deimination of arginine residues in histones to citrullines, a
posttranslational modification catalyzed by peptidyl argi-
nine deaminase that aids in chromatin decondensation.
Hypercitrullinated histones were detected in NETs released
by neutrophils activated by LPS and H2O2 but not in
neutrophils treated with staurosporine or camptothecin to
induce apoptosis [16, 17].
In NETosis, global chromatin decondensation and
disintegration of the nuclear membrane occurs concomitant
with cytoplasmic granule dissolution, allowing the NET
components to mix in the cytoplasm prior to their
extracellular release [4, 15]. The negatively charged DNA
backbone of NETs also provides a framework for activation
of the contact system [13], which is comprised of the
serum-derived serine proteases factor XI, factor XII, and
plasma kallikrein together with the nonenzymatic high-
molecular-weight cofactor, kininogen [18]. Activation of
the contact system results in generation of the potent
proinflammatory mediator bradykinin, as well as break-
down peptide fragment of HK with potent antimicrobial
properties [19]. The humoral pattern recognition receptor
pentraxin 3 is also present in neutrophil-specific granules
and localizes to NETs where it may play a role in the control
of fungal pathogens such as Aspergillus fumigatus [20].
Mast cell extracellular traps
ET formation was first thought to be restricted to neutrophils,
as stimulation of peripheral blood mononuclear cells with
PMA or H2O2 did not induce release of similar DNA-based
extracellular structures [4]. However, recent investigations
have revealed that another tissue granulocyte important to
innate host defense, the mast cell (MC), is also able to
elaborate its nuclear DNA to produce antimicrobial ETs [21].
MCs are prevalent at sites interfacing with the environment
such as the respiratory tract and skin. Largely studied in the
context of allergic diseases [22] ,t h er o l eo fM C si nh o s t
defense against bacterial pathogens has attracted increasing
attention [23]. MCs prestore tumor necrosis factor α in their
secretory basophilic granules, which can be released imme-
diately upon activation by pathogens to promote early
neutrophil recruitment and bacterial clearance [24]. MCs
Table 1 Factors or microbes inducing formation of extracellular traps
Factor or Microbe Cellular origin of extracellular trap References
Interleukin 8 (IL-8) Neutrophils [3]
Lipopolysaccharide (LPS) Neutrophils [3]
Phorbol myristate acetate (PMA) Neutrophils, mast cells [3, 21]
Hydrogen peroxide Neutrophils, mast cells [4, 21]
Platelet TLR-4 Neutrophils [6]
Interferon (IFN) γ + C5a Neutrophils, eosinophils [5, 32]
Interferon (IFN) γ + LPS Eosinophils [32]
Interferon (IFN) γ + eotaxin Eosinophils [32]
IL-5 + LPS/C5a/eotaxin Eosinophils [32]
Interferon (IFN) α + C5a Neutrophils [5]
GM-CSF + C5a Neutrophils [5]
Staphylococcus aureus Neutrophils, mast cells [4, 21]
Streptococcus pyogenes Neutrophils, mast cells [7, 21]
Streptococcus pyogenes
M1 protein–fibrinogen complex Neutrophils, mast cells [12, 13]
Pseudomonas aeruginosa Mast cells [21]
Mycobacterium tuberculosis Neutrophils [8]
Mycobacterium canettii Neutrophils [8]
Candida albicans (hyphae or yeast) Neutrophils [10]
Escherichia coli Neutrophils [9]
Leishmania amazonensis Neutrophils [11]
Leishmania amazonensis, surface lipophosphoglycan Neutrophils [11]
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lular uptake through oxidative and nonoxidative antimicrobial
mechanisms, similar to traditional phagocytes such as
neutrophils and macrophages [25]. Potent broad-spectrum
AMPs such as cathelicidin and β-defensins are present in MC
granules and are secreted upon bacterial stimulation [26, 27].
Recently, confocal fluorescent microscopy and scanning
electron microscopy were used to demonstrate that both
human and murine MCs exert extracellular antimicrobial
activity through ROS-dependent dissolution of the nuclear
membrane and elaboration of structures that strongly
resembled NETs [21]. Mast cell extracellular trap (MCET)
production was documented in response to various patho-
gens including S. aureus, Pseudomonas aeruginosa, and S.
pyogenes [21] and, like NET formation, in response to the
purified M1 protein of S. pyogenes [12]. The major
components of human MCETs are DNA, histones, MC-
specific granule proteins such as tryptase, and the cath-
elicidin AMP LL-37. Bacterial entrapment was required for
antimicrobial activity since dismantling the MCETs struc-
ture strongly reduced bacterial killing [21]. However, in
contrast to NETs, DNase alone was not sufficient to
dismantle MCETs; additional treatment with tryptase-
degrading myeloperoxidase was required for this purpose.
Wartha and Henriques-Normark [28] have recently recom-
mended recoining the term “NETosis” to “ETosis,” consis-
tent with the relevance of this phenomenon for additional
cell types.
Catapulting mitochondria and eosinophil extracellular
traps
Eosinophils, sharing many similarities with MC, are a
specialized and rather enigmatic granulocytic cell type derived
from the bone marrow. Generally residing in hematopoietic
andlymphaticorganssuchasthespleenandlymphnodes[29],
eosinophils can also infiltrate stomach, small intestine, and
colon, where they are seen in association with inflammatory
bowel disease (IBD) and a spectrum of conditions now
known as eosinophil-associated gastrointestinal disorders
(EGIDs) [30, 31]. Although the reliable induction of
eosinophil counts in response to parasitic nematode infections
suggest they serve an immune role, the exact function(s) of
eosinophils in host defense have remained unclear.
However, very recently, Yousefi et al. identified a
remarkable phenomenon of catapult-like ejection of
mitochondrial DNA by eosinophils with the potential
to contribute to antibacterial defense [32]. Examining
infectious foci from biopsies of patients with IBD or
Fig. 2 Model for formation of neutrophil extracellular traps.
Neutrophils are activated by contact with microbial pathogens
different stimuli such as LPS, IL-8, PMA, IFN-α/γ + C5a or GM-
CSF + C5a. Stimulation of neutrophils results in the activation of
NADPH oxidases and the formation of reactive oxygen species
(ROS). ROS signaling is required for the novel cell death pathway of
ETosis, which is characterized by the disruption of the nuclear
membrane, chromatin decondensation, and the mixing of nuclear
contents with cytoplasmic and granular proteins. As a final step,
nuclear and granular components are released by the dead cell
generating the extracellular traps. Extracellular traps have the ability
to entrap and/or kill different microbes, while also enhancing
proinflammatory innate immune responses
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containing material extruding from gastrointestinal eosi-
nophils. The authors then showed that, when blood
eosinophils were primed in vitro with IL-5 or interferon
γ (IFN- γ) and subsequently stimulated with LPS, C5a, or
the eosinophil chemokine eotaxin, they would release
mitochondrial (but not nuclear) DNA, thus forming extracel-
lular traps containing antibacterial eosinophilic cationic
protein and major basic protein [32]. Similar to NETs and
MCETs, treatment with DNase resulted in the disappearance
of the eosinophil-derived extracellular DNA structures and
in the abolishment of extracellular bacterial killing.
Like NETs and MCETs, the eosinophil ET process is
dependent on ROS production but importantly does not
represent a specialized form of cell death since the
eosinophil remains viable after ejection of its mitochondrial
DNA (differences highlighted in Table 2). A role in defense
of compromised gastrointestinal epithelium is postulated,
and transgenic hypereosinophilic mice were shown to be
less susceptible to septicemia following cecal ligation
puncture [32]. However, the in vivo function of
eosinophil-derived ETs remains to be demonstrated, and it
is at least conceivable that the release of proinflammatory
eosinophil contents represents part of the underlying
pathophysiology of IBD and EGID, as opposed to an
adaptive antibacterial defense mechanism [33].
Association of ETs with specific disease conditions
There is increasing evidence that ETs play an important role
in several infectious as well as noninfectious diseases
(Table 3). The literature to date has demonstrated how a
variety of microbes are entrapped within and/or killed by
ET: Gram-positive bacteria (S. aureus, S. pyogenes, S.
pneumoniae, L. monocytogenes), Gram-negative bacteria
(E. coli, Salmonella enterica, Shigella flexneri, Haemophi-
lus influenzae, Pseudomonas luminescens), mycobacteria
(M. tuberculosis), fungi (C. albicans), and parasites (L.
amazonensis). It remains uncertain whether viruses are
entrapped by ETs. The molecular mechanisms involved in
entrapment of the microbes are not known, but it is
postulated that electrostatic interactions between the cat-
ionic component of NETs and the anionic surface of
microorganisms play a role in this process [34]. After
disruption of extracellular traps with DNase or DNase/
proteinase mixtures, the extracellular antimicrobial activity
of neutrophils, eosinophils, or MCs is eliminated [4, 21, 32].
Several studies have provided in vivo demonstrations of
ET formation during infection, including spontaneous
human appendicitis [3], children with Plasmodium falcipa-
rum malaria [35], patients with cutaneous leishmaniasis
[11], Shigella-induced experimental dysentery in rabbits
[3], H. influenzae-associated otitis media in chinchillas
[36], murine models of pneumococcal pneumonia [37], S.
pyogenes necrotizing soft tissue infection [7], and poly-
microbial sepsis after cecal ligation and puncture [32].
Recently, NETs were also detected in bovine mastitis
induced by pathogenic E. coli, where neutrophil phagocy-
tosis and oxidative burst have been shown to be hampered
by milk fat, proteins, or hyperketonemia [9, 38].
If ETs indeed serve a critical innate immune function,
then deficiencies in ET formation would be postulated
to render the individual host more susceptible to
infection. Some evidence is beginning to emerge along
these lines. For example, human newborns are known to
have qualitative defects in neutrophil function that
contribute to sepsis and other infectious complications.
Table 2 Comparison of formation of extracellular traps by different cell types
Neutrophils Mast cells Eosinophils
Main backbone DNA DNA, tryptase DNA
Degradation of
traps
DNase DNase (tryptase-
degrading)
myeloperoxidase
DNase
Further
identified
components
Histones, elastase, myeloperoxidase, cathepsin G, LL-37, PTX-3,
gelatinase, lactoferrin, bactericidal permeability increasing pro-
tein (BPI), peptidoglycan recognition proteins (PGRPs)
Histones, LL-37 Eosinophilic cationic protein
(ECP), major basic protein
(MBP)
Final cell status Dead Dead Alive
ROS
dependent
Yes Yes Yes
Origin of DNA Nuclear Nuclear Mitochondrial
Disruption of
nuclear
membrane
Yes Yes No
Time frame 10 min to 4 h 10 min to 4 h Seconds
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term and preterm infants fail to form NETs when
activated by inflammatory agonists that readily stimulate
NET formation in adult neutrophils (e.g., LPS, PMA);
consequently, a defect in the ability of the newborn
neutrophils to carry out extracellular bacterial killing is
appreciated [39]. Neutrophils and eosinophils from individ-
uals with chronic granulomatous disease, an hereditary
dysfunction of NADPH oxidase function and respiratory
burst,areunabletoformneutrophiloreosinophilextracellular
traps [4, 32], an observation that might further explain the
marked susceptibility of these patients to recurrent life-
threatening bacterial and fungal infections [40].
ETs are now recognized to be present in certain
noninfectious diseases, as summarized in Table 2.N E T s
are also produced during sepsis after platelet-mediated
neutrophil activation, and, though contributing to bacterial
entrapment, the accumulation of NETs and their compo-
nent proteases may promote vascular endothelial injury
and ischemia [6]. Preeclampsia, a potentially life-
threatening pregnancy-related disorder, is characterized
by neutrophil activation and a previously unexplainable
high level of circulatory DNA of maternal origin [41–43].
In this scenario, NETs were able to entrap proinflamma-
tory syncytiotrophoblast microparticles and thereby pos-
sibly control the immune response by keeping
inflammatory mediators from diffusing to adjacent healthy
tissue [44]. Such a function for MCETs, i.e., to minimize
collateral tissue damage by sequestering harmful com-
pounds of MC granules such as proteolytic enzymes or
histamines at the site of infection, has also been postulated
[21].
It is interesting to speculate that dysregulated leakage of
nucleic acids from neutrophils or MC or perhaps the failure
of the host to efficiently clear ETs after their induction may
have detrimental consequences leading to autoimmune
phenomenon as seen in lupus erythematosus, where anti-
bodies directed against nucleic acids and histones are a
pathognomonic feature [3]. Recently, Neeli et al. [16]
showed that deiminated histones, a covalently modified
form of a prominent nuclear autoantigen, are released to the
extracellular space as part of formation of NETs. The
authors hypothesized that the possible association of a
modified autoantigen with microbial components could, in
predisposed individuals, increase the risk of autoimmunity
[16]. In P. falciparum malaria, circulating neutrophil-
derived ETs bearing adherent parasites and erythrocytes
are seen in concert with antinuclear immunoglobulin G.
However, since a genetic model to eliminate expression of
NETs or MCETs has not been realized, verification of the
Table 3 Association of extracellular traps with diseases
Infectious disease Role of extracellular traps References
Staphylococcus aureus Capture and kill bacteria [3]
Streptococcus pyogenes Capture and kill bacteria [7]
Streptococcus pneumoniae Capture and prevent spreading of bacteria [37]
Salmonella enterica serovar
Typhimurium
Capture and kill bacteria [3]
Shigella flexneri Capture and kill bacteria [3]
Escherichia coli Capture and kill bacteria [9]
Candida albicans Capture and kill hyphae or yeast [10]
Mycobacterium tuberculosis Capture bacteria [8]
Mycobacterium canettii Capture bacteria [8]
Listeria monocytogenes Capture and kill bacteria [8]
Haemophilus influenzae Biofilm formation and persistence [36]
Photorhabdus luminescens Capture and kill bacteria [53]
Plasmodium falciparum Unclear [35]
Intestinal spirochetosis Unclear [32]
Leishmania amazonensis Capture and kill parasite [11]
Bacterial sepsis Upon platelet activation, potential endothelial injury [6]
Noninfectious disease
Appendicitis Unclear [3]
Human preeclampsia Entrap and control release of proinflammatory placenta-derived syncytiotrophoblast
microparticles (STBM)
[44]
Infertility of horses Entrapment of sperm cells [54]
Autoimmune reactions Unclear [3, 16]
780 J Mol Med (2009) 87:775–783full contribution(s) of ETs to infectious, noninfectious, or
autoimmune diseases remains challenging.
Mechanisms of microbes to avoid entrapment or killing
by ETs
Perhaps the best evidence for a critical role of ETs in innate
host defense has come from recent experimentation
manipulating the microbial side of the host–pathogen
equation. These studies have shown that certain leading
bacterial pathogens have evolved mechanisms to avoid ET-
based immune clearance, either through ET degradation,
resistance to the intrinsic antimicrobial effectors with ETs,
or the suppression of ET production (summarized in
Table 4).
Shortly after the discovery of NETs, several independent
groups demonstrated the ability of pathogenic bacteria to
avoid entrapment and killing by NETs by production of
DNA-degrading nucleases. Targeted elimination of DNase
production in S. pyogenes, and in particular the potent
bacteriophage-encoded DNase Sda1, rendered the pathogen
more susceptible to neutrophil extracellular killing [7, 45];
correspondingly, heterologous expression of Sda1 in other
bacterial strains conferred an ability to degrade NETs and
resist neutrophil killing [7]. DNase-deficient GAS were
attenuated for virulence in a murine necrotizing fasciitis
model [7, 45], and pharmacological inhibition of DNase
activity with G-actin provided a therapeutic benefit against
GAS proliferation and tissue damage [7]. Acquisition of the
bacteriophage encoding Sda1, and its upregulation during
the genetic and phenotypic switch to the invasive pheno-
type [46], may help explain the global dissemination of a
hypervirulent clone of M1 serotype S. pyogenes associated
with severe human infections including necrotizing fasciitis
[47]. Similar mutagenesis studies elegantly demonstrated
that production of the DNase EndA by S. pneumoniae
could degrade NETs, promote bacterial resistance to
neutrophil killing, and contribute to virulence in a murine
model of pneumococcal pneumonia [37].
S. pneumoniae expression of polysaccharide capsule, a
classical virulence factor of the pathogen, significantly
reduced the trapping of the bacterium within NETs,
providing another potential mechanistic contribution of
capsule to disease progression [48]. Cationic antimicrobial
peptides such as cathelicidin are important effectors of
bacterial killing within NETs. S. pneumoniae mutants
lacking positively charged D-alanyl residues of their surface
lipoteichoic acid (LTA) were more susceptible to killing by
NET components, suggesting that these gene-encoded
surface modifications are important for survival, especially
in settings of low encapsulation [48]. D-alanylation of LTA
by the dlt operon is known to contribute to resistance of S.
pyogenes [49] and S. aureus [50] to cathelicidin antimicro-
bial peptides, which in turn are localized within NETs.
Recently, it was shown that the surface-expressed M1
protein of S. pyogenes is able to bind cathelicidin LL-37
and prevent its bactericidal activity and, as a result, promote
GAS survival within NETs and MCETs [12]. Nontypeable
H. influenzae, a major etiologic agent of middle ear
infections, expresses key lipooligosaccharide moieties that
promote biofilm formation and allow the organism to
survive within NETs in the middle ear cavity [36].
The inhibition of NET production provides a proximal
means for pathogen avoidance of neutrophil extracellular
killing. The chemokine IL-8, released by epithelial cells at
the focus of infection and by recruited neutrophils
themselves in amplifying the immune response, is a potent
inducer of NET formation [4, 44]. S. pyogenes expresses a
peptidase, SpyCEP, which cleaves and inactivates IL-8.
Expression of SpyCEP was shown to reduce the level GAS-
stimulated NET production and thus help the pathogen
evade neutrophil extracellular killing [51]. Streptococcus
agalactiae, a major cause of invasive infections in human
newborns, expresses an exopolysaccharide capsule contain-
ing terminal sialic acid residues mimicking a common
Table 4 Mechanisms of microbes to avoid entrapment/killing in extracellular traps
Microbe Evasion strategy References
Streptococcus pyogenes NET degradation by DNase Sda1/2 [7, 45]
Streptococcus pyogenes Reduction of NET production by IL-8 protease SpyCEP [51]
Streptococcus pyogenes Resistance against LL-37-mediated killing within NETs/MCETs by surface M1 protein [12]
Streptococcus
pneumoniae
NET-degradation by DNase EndA [37]
Streptococcus
pneumoniae
Preventing entrapment within NETs by capsule (serotype 1, 2, 4, 9 V) and D-alanylated lipoteichoic
acids (LTA)
[48]
Haemophilus
influenzae
Resistance against NET-killing by surface lipooligosaccharides [36]
Streptococcus
agalactiae
Suppression of NETs by sialic acid engagement of Siglec receptors and consequent inhibitory signaling [52]
J Mol Med (2009) 87:775–783 781glycoepitope on human cell surfaces. It was recently shown
that S. agalactiae can engage Siglec receptors on human
neutrophils via these sialic acid moieties, leading to
negative cell signaling, suppression of the oxidative burst,
and diminished NET production, thereby promoting resis-
tance to neutrophil killing [52].
Summary
The process of microbial phagocytosis by white blood cells
was originally described by the Russian microbiologist Ilya
Metchnikov, a discovery for which he was awarded the
Nobel Prize in Medicine or Physiology just over a century
ago. The recent discoveries summarized herein of DNA-
based ETs dramatically expand the antimicrobial repertoire
of these highly specialized leukocytes and thus extend the
playing field on which the battle against pathogens is
fought from the intracellular to the extracellular compart-
ment. The tenacious constituency of pus generated at
primary foci of infection following neutrophil infiltration
can now be viewed as a more physiologic and purposeful
phenomenon—an immunological quicksand, so to speak,
that serves to prevent spread and aid in sterilization by
physically trapping microorganisms and directly exposing
them to antimicrobial histones, peptides, and proteases.
Leading human pathogens, it would seem, demonstrate
mechanisms to avoid or escape ET that may be as pivotal to
their virulence potential as resistance to phagocytosis; many
more such ET survival capacities are certain to be
discovered. And as for many other aspects of our immune
defense, too much of a good thing can prove detrimental,
and potential contributions of NETs to inflammatory and
autoimmune diseases merit further exploration.
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